Skip to main content
. 2018 Mar 2;8:3933. doi: 10.1038/s41598-018-22194-z

Figure 2.

Figure 2

Protein expression in abdominal subcutaneous adipose tissue. Expression of proteins involved in the lipolytic pathway (ATGL, n = 12, (A); HSL, n = 13, (B); HSL serine 660 phosphorylation, n = 13, (C), the natriuretic peptide signaling pathway (NPR-A, n = 12, D) and mitochondrial oxidative metabolism (total OXPHOS, n = 13, E) expressed as fold change relative to baseline for each treatment arm (Sacubitril/valsartan: LCZ696 or Amlodipine: AMLO). Data are expressed as mean ± S.E.M. White bars: baseline values; black bars: post-treatment values. Representative (cropped) western blots of which membranes were probed with antibodies directed against total ATGL, total HSL, phosphorylated HSL (p-HSL) on Ser660 and NPRA (F) and uncropped western blots of OXPHOS protein expressions (G).